A Clinical Study to Assess the Efficacy and Safety of GSK2402968 in Subjects With Duchenne Muscular Dystrophy

Clinical trial NCT01254019 · COMPLETED

Trial details

NCT number: NCT01254019
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Muscular Dystrophies

Start date: 2010-12-02
Primary completion: 2013-06-28
Enrollment: 186

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.